Thrombocytopenia Treatment Market - Opportunity Analysis, 2018-2026
The thrombocytopenia treatment market is driven by increasing prevalence of thrombocytopenia globally.
The thrombocytopenia treatment market is driven by increasing prevalence of thrombocytopenia globally.
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
<strong>Thrombocytopenia</strong> <strong>Treatment</strong> <strong>Market</strong><br />
GLOBAL INDUSTRY INSIGHTS, TRENDS,<br />
OUTLOOK, AND OPPORTUNITY ANALYSIS, <strong>2018</strong>-<br />
<strong>2026</strong><br />
© Coherent market Insights. All Rights Reserved
REPORT DESCRIPTION<br />
<strong>Thrombocytopenia</strong> <strong>Treatment</strong> <strong>Market</strong> Overview<br />
<strong>Thrombocytopenia</strong> is a disorder in which a patient has low level of platelets in the blood. The major causes of thrombocytopenia are<br />
inefficient production of platelets, platelet splenic sequestration, and accelerative destruction of platelets. The most common<br />
ineffective production of thrombocytes are due bone marrow failure syndrome such as myelodysplastic syndrome and aplastic<br />
anemia. <strong>Thrombocytopenia</strong> can be inherited or acquired. In 2014, According to a research article published in Professional Med J,<br />
2014, entitled Frequency of <strong>Thrombocytopenia</strong>, the frequency of thrombocytopenia is higher for people aged 60 years and above,<br />
suffering from non-cirrhotic liver disease. However, rampant discovery coupled with the ability to clone thrombopoietin has<br />
resulted in new treatment opportunities for clinical manifestation.<br />
More specific treatment plans usually depend on the underlying etiology of thrombocytopenia. In most cases the underlying cause<br />
of thrombocytopenia is not known, especially in the case of severe bleeding. In September 2015, Lusutrombopag, an orally<br />
bioavailable, small molecule thrombopoietin (TPO) receptor agonist developed by Shionogi Inc., received approval by<br />
Pharmaceuticals and Medical Devices Agency of Japan. Lusutrombopag helped enhance chronic liver disease (CLD) associated<br />
with thrombocytopenia for patients scheduled to undergo invasive procedures. Lusustrombopag acts specifically on human<br />
thrombopoietin (TPO) receptors and stimulates signaling pathways that trigger the proliferation and differentiation of bone marrow<br />
cells into megakaryocytes. Thus, increasing the blood platelet count. However, patients treated with Lusustrombopag further<br />
showed higher counts of blood leukocytes and erythrocyte. Furthermore, in June 2017, FDA accepted application for new oral<br />
investigational drug,<br />
Click To Continue Reading on <strong>Thrombocytopenia</strong> <strong>Treatment</strong> <strong>Market</strong><br />
© Coherent market Insights. All Rights Reserved
REPORT DESCRIPTION<br />
<strong>Thrombocytopenia</strong> <strong>Treatment</strong> <strong>Market</strong> Taxonomy:<br />
By Drug Class:<br />
Glucocorticoids<br />
Lysosomal Enzyme<br />
Platelet Stimulating Agent<br />
By Distribution Channel:<br />
Hospital Pharmacies<br />
Retail Pharmacies<br />
Online Pharmacies<br />
The use of this drug is approved in the U.S and registered in Europe. The low dose of Eltrombopag is<br />
effective and safe for the prevention of CIT. Case Reports Hematology, 2017, reports that long-term<br />
usage of thrombopoetin (TPO) receptor agonists is safe for patients suffering from chronic lymphocytic<br />
leukemia associated with Immune thrombocytopenia, as they are a non-immunosuppressive drugs.<br />
Request Sample Copy of this Business Report @<br />
https://www.coherentmarketinsights.com/insight/request-sample/1484<br />
© Coherent market Insights. All Rights Reserved
REPORT DESCRIPTION<br />
<strong>Thrombocytopenia</strong> <strong>Treatment</strong> <strong>Market</strong>: Key Players<br />
Major players involved in the global thrombocytopenia <strong>Treatment</strong> <strong>Market</strong> include:<br />
●<br />
3SBio Inc.<br />
●<br />
Amarillo Biosciences, Inc.<br />
●<br />
Amgen Inc.<br />
●<br />
Baxalta Incorporated<br />
●<br />
Bayer AG<br />
●<br />
Boehringer Ingelheim GmbH<br />
●<br />
Bristol-Myers Squibb Company<br />
●<br />
Cellerant Therapeutics, Inc.<br />
●<br />
Eisai Co., Ltd.<br />
Access Table of Content (TOC) Of the Report:<br />
https://www.coherentmarketinsights.com/ongoing-insight/toc/1484<br />
© Coherent market Insights. All Rights Reserved
ABOUT COHERENT MARKET INSIGHTS<br />
ABOUT US<br />
Coherent <strong>Market</strong> Insights is a global market intelligence and consulting<br />
organization focused on assisting its plethora of clients achieve transformational<br />
growth by helping them make critical business decisions. We are headquartered in<br />
India, with an office at the global financial capital in the U.S. Our client base<br />
includes players from across all business verticals in over 150 countries worldwide.<br />
We are uniquely positioned to help businesses around the globe deliver practical<br />
and lasting results through various recommendations about operational<br />
improvements, technologies, emerging market trends and new working methods.<br />
We offer both customized and syndicated market research reports that help our<br />
clients create visionary growth plans to provide traction to their business. We<br />
meticulously study emerging trends across various industries at both the global<br />
and regional levels to identify new opportunities for our clientele.<br />
SERVICES<br />
INDUSTRY ANALYSIS<br />
MARKET INTELLIGENCE<br />
SERVICES<br />
CUSTOMIZED<br />
RESEARCH<br />
CONSULT STUDIES<br />
SYNDICATED RESEARCH<br />
COUNTRY SPECIFIC<br />
STUDIES<br />
© Coherent market Insights. All Rights Reserved
ABOUT COHERENT MARKET INSIGHTS<br />
Industries we cater<br />
SECTOR COVERAGE<br />
Healthcare<br />
BIOTECHNOLOGY CLINICAL DIAGNOSTIC HEALTHCARE IT<br />
MEDICAL DEVICES<br />
MEDICAL IMAGING<br />
Chemicals & Materials<br />
PHARMACEUTICAL<br />
Bulk Chemicals Advanced Materials Speciality and Fine<br />
Chemicals<br />
Green Chemicals<br />
Food Ingredients<br />
Cosmetic<br />
Ingredients<br />
Polymers &<br />
Resins<br />
© Coherent market Insights. All Rights Reserved
ABOUT COHERENT MARKET INSIGHTS<br />
KEY STATS<br />
100+<br />
Insights Published Per Year<br />
150+<br />
Consulting Projects Till Date<br />
125+<br />
Clients Worldwide Per Year<br />
RESEARCH SOLUTIONS<br />
CONSULT<br />
PROJECTS<br />
SURVEY<br />
RESEAR<br />
CH<br />
FEASIBILITY<br />
STUDIES<br />
EXCEL<br />
FORECAST<br />
DATABASE<br />
GLOBAL<br />
REPORTS<br />
COUNTRY<br />
ANALYSIS<br />
CUSTOMIZED<br />
SOLUTIONS<br />
COMPETITIVE<br />
ASSESSMENT<br />
110+<br />
Analysts and Contract Consultants<br />
TECHNOLOGY<br />
SNIPPETS<br />
Coherent <strong>Market</strong> Insights excels at offering unmatched actionable market intelligence across various industry verticals, including<br />
chemicals, healthcare, and food & beverages, to name a few. We implement holistic market research methodology in order to result in<br />
the best possible market research reports across various industries worldwide. Based on our unmatched expertise across various<br />
industries—no matter how large or small, how complex or unique—we help our clients achieve better outcomes with uniquely<br />
designed and highly customized solutions. Our coverage includes insights that help our clients ensure sustained growth in developed<br />
markets and also key inputs to help them tap into emerging markets and exploit the plethora of opportunities posed therein.<br />
© Coherent market Insights. All Rights Reserved
THANK YOU<br />
To know more about us, visit our website:<br />
www.coherentmarketinsights.com<br />
For sales queries or new topics email us on:<br />
sales@coherentmarketinsights.com<br />
For other queries contact:<br />
Mr. Shah<br />
(Manager - Business Development)<br />
Coherent <strong>Market</strong> Insights<br />
sales@coherentmarketinsights.com<br />
+1-206-701-6702<br />
© Coherent market Insights. All Rights Reserved
Change language